Lots of interesting abstracts and cases were submitted for TCTAP 2022. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!
TCTAP A-004
Acute Myocardial Infarction Cardiogenic Shock (AMICS) in Middle Eastern Patients, Insights From a 23-Years Registry
By Ghiath Baroudy, Mohamed Salah Abdelghani, Abdul Rahman Arabi, Rajvir Singh, Jassim Al Suwaidi, Awad Alqahtani, Hajar Albinali
Presenter
Ghiath Sadek Baroudy
Authors
Ghiath Baroudy1, Mohamed Salah Abdelghani2, Abdul Rahman Arabi3, Rajvir Singh4, Jassim Al Suwaidi4, Awad Alqahtani4, Hajar Albinali2
Affiliation
Hamad Medical Corporation Heart Hospital, Qatar1, HMC Heart Hospital, Qatar2, Hamad Medical Corporation, Qatar3, Hamad Medical Corporation (HMC), Doha, Qatar4
View Study Report
TCTAP A-004
Acute Coronary Syndromes (STEMI, NSTE-ACS)
Acute Myocardial Infarction Cardiogenic Shock (AMICS) in Middle Eastern Patients, Insights From a 23-Years Registry
Ghiath Baroudy1, Mohamed Salah Abdelghani2, Abdul Rahman Arabi3, Rajvir Singh4, Jassim Al Suwaidi4, Awad Alqahtani4, Hajar Albinali2
Hamad Medical Corporation Heart Hospital, Qatar1, HMC Heart Hospital, Qatar2, Hamad Medical Corporation, Qatar3, Hamad Medical Corporation (HMC), Doha, Qatar4
Background
Limited information regarding the clinical characteristics and outcome of AMICS in Middle Eastern patients.
Objectives:
Objectives:
Methods
Retrospective analysis of the 23-year registry data (Jan 1991 to May 2013) of cardiac patients hospitalized at Hamad General Hospital and Heart Hospital, Doha, Qatar.
Results
A total of 16,070 consecutive patients were admitted with Acute MI during the study period, of whom 1481 (9.2%) had a diagnosis of AMICS. The incidence had increased from 7% in the first quarter of the study to 11% in the last quarter (P=0.01). Compared to acute MI without cardiogenic shock, AMICS patients were older (59.1±12.6 vs. 53.1±11.7, P=0.001) more likely to have diabetes (57% vs. 39%, P=0.001), hypertension (55% vs. 37%, P=0.001), dyslipidemia (12% vs. 9%, P=0.005), chronic kidney disease (11% vs. 3%, P=0.001) and history of prior MI (22% vs. 11%, P=0.001), but they are less likely to be males (75% vs. 89%, P=0.001) or to be smokers (25% vs. 37P=0.001).AMICS patients had significantly higher in-hospital mortality rate (43.5% versus 2.5 %, P= value 0.001).The mortality rate declined from 74% in the first quarter to less than 20% in the last quarter.
Conclusion
The incidence of AMICS is increasing, Patients with AMICS are older and more likely to have traditional risk factors other than smoking, Despite the significant improvement in survival, the mortality rate is still very high.